Ekaterini Kotsopoulou

A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1 <i>gag-pol</i> Gene

Ekaterini Kotsopoulou, V. Narry Kim, Alan J. Kingsman et al. · Journal of Virology · 2000 · 229 citations

Life Sciences, Molecular Biology, Molecular Genetics +17

The <i>scl</i> +18/19 Stem Cell Enhancer Is Not Required for Hematopoiesis: Identification of a 5′ Bifunctional Hematopoietic-Endothelial Enhancer Bound by Fli-1 and Elf-1

Berthold Göttgens, Cyril Broccardo, María J. Sánchez et al. · Molecular and Cellular Biology · 2004 · 88 citations · Full text

Life Sciences, Developmental Biology, Genetics +17

Enriching leukapheresis improves T cell activation and transduction efficiency during CAR T processing

Elsa Noaks, Carlotta Peticone, Ekaterini Kotsopoulou et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 61 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Phase 1 First-in-Human Study of AUTO2, the First Chimeric Antigen Receptor (CAR) T Cell Targeting APRIL for Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Rakesh Popat, Sonja Zweegman, Jim Cavet et al. · Blood · 2019 · 49 citations

Life Sciences, Hematology, Immunology +16

Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy Targeting CD19 and CD22, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL): Amelia Study

Persis Amrolia, Robert Wynn, Rachael Hough et al. · Blood · 2019 · 41 citations

Medicine, Hematology, Oncology +15